Testing effectiveness (Phase 2)Ended earlyNCT03159364
What this trial is testing
Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections
Who this might be right for
Pathogen InfectionEBV InfectionCMV Infection+4 more
Shenzhen Geno-Immune Medical Institute 100